Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.

[Mesoblast] MESOBLAST LIMITED : MSB ASX NEW DIRECTOR - 10 MAY 2012

Started by ImmInst , May 10 2012 02:23 AM

Please log in to reply

252 replies to this topic

#31 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 17 May 2012 - 01:02 PM

Aastrom Biosciences to Present at World Stem Cells & Regenerative Medicine ...
MarketWatch (press release) - 1 hour ago

ANN ARBOR, Mich., May 17, 2012 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) , the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, ...

Ascendiant Capital Markets Analysts Begin Coverage on Aastrom Biosciences (ASTM) - Movie News Guide (blog)

View the full article

#32 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 17 May 2012 - 08:53 PM

Osiris Wins Canadian Approval for First Stem-Cell Therapy
Bloomberg - 7 seconds ago

Osiris Therapeutics Inc. (OSIR) said it won the world's first approval for a stem-cell drug, gaining clearance in Canada to sell Prochymal for a disease that can attack patients who received bone-marrow transplants.

View the full article

#33 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 06:26 PM

Wednesday's Top Upgrades (and Downgrades)
DailyFinance - May 16, 2012

By Rich Smith, The Motley Fool Stocks go up, stocks go down -- and so do analysts' opinions of them. This series, brought to you by Yahoo!

View the full article

#34 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 17 May 2012 - 08:54 PM

Osiris Wins Canadian Approval for First Stem-Cell Therapy
BusinessWeek - 3 hours ago

By Meg Tirrell on May 17, 2012 Osiris Therapeutics Inc. (OSIR) (OSIR) said it won the world's first approval for a stem-cell drug, gaining clearance in Canada to sell Prochymal for a disease that can attack patients who received bone-marrow transplants ...

View the full article

#35 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 18 May 2012 - 09:05 AM

Aastrom Biosciences to Present at World Stem Cells & Regenerative Medicine ...
Review seeker (press release) - 2 hours ago

By Globenewswire ANN ARBOR, Mich., May 17, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, ...

View the full article

#36 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 18 May 2012 - 11:58 AM

Aastrom Biosciences to Present at World Stem Cells & Regenerative Medicine ...
PharmaLive (press release) (subscription) - 2 hours ago

ANN ARBOR, Mich., May 17, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that ...

Ascendiant Capital Starts Aastrom Biosciences (ASTM) at Strong Buy; Leading ... - StreetInsider.com (subscription)

View the full article

#37 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 18 May 2012 - 05:02 PM

Augusta Resource Corporation Announced The Retirement Of Senior Vice President ...
Galaxy Stocks - 2 hours ago

Augusta Resource Corporation (NYSE Amex:AZC) recently announced the retirement of Raghunath N. Reddy as Senior Vice President and Chief Financial Officer (CFO) and appointed Joseph M. Longpré as his successor, effective May 9, 2012.

View the full article

#38 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 18 May 2012 - 05:02 PM

Augusta Resource Corporation Announced The Retirement Of Senior Vice President ...
Galaxy Stocks - May 18, 2012

View the full article

#39 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 18 May 2012 - 05:02 PM

Augusta Resource Corporation Announced The Retirement Of Senior Vice President ...
Galaxy Stocks - May 18, 2012

View the full article

#40 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 21 May 2012 - 12:28 PM

Weekly Stock Watch: FB, NBY, DNDN, AMPE, PFE, HGSI, ACTC, SGYP, IRWD, CTSO ...
The Mumbai Times - 3 hours ago

The 20 analysts offering 12-month price forecasts for Dendreon Corp have a median target of 12.00, with a high estimate of 21.00 and a low estimate of 4.00.

View the full article

#41 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 21 May 2012 - 12:15 PM

Osiris Therapeutics (NASDAQ:OSIR) Wins Stem Cell Medicine Approval; Shares Sky ...
PT News - 4 hours ago

Osiris Therapeutics, Inc (NASDAQ:OSIR) moved up after the corporation reported that it got the world's primary approval for a stem- cell medicine, gaining clearance in Canada to vend Prochymal for a infection that can attack patients who received ...

Osiris Therapeutics (NASDAQ:OSIR) Wins World's First Stem-Cell Therapy Approval - Gaining Green

View the full article

#42 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 18 May 2012 - 11:58 AM

Aastrom Biosciences to Present at World Stem Cells & Regenerative Medicine ...
PharmaLive (press release) (subscription) - May 18, 2012

Ascendiant Capital Starts Aastrom Biosciences (ASTM) at Strong Buy; Leading ... - StreetInsider.com (subscription)

View the full article

#43 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 17 May 2012 - 01:02 PM

Aastrom Biosciences to Present at World Stem Cells & Regenerative Medicine ...
MarketWatch (press release) - May 17, 2012

Ascendiant Capital Markets Analysts Begin Coverage on Aastrom Biosciences (ASTM) - Movie News Guide (blog)

View the full article

#44 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 06:26 PM

Wednesday's Top Upgrades (and Downgrades)
DailyFinance - May 16, 2012

By Rich Smith, The Motley Fool Stocks go up, stocks go down -- and so do analysts' opinions of them. This series, brought to you by Yahoo!

View the full article

#45 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 01:38 PM

Upgrades & Downgrades: Bulls Run on Dunkin'
Minyanville.com - May 16, 2012

By Justin Sharon May 16, 2012 9:30 am MINYANVILLE ORIGINAL Zeus, the Greek god of thunder, was angry yesterday, as France's freshly sworn-in president can attest to after a pitch-perfect metaphor for Europe's fiscal crisis.

View the full article

#46 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 12 May 2012 - 03:11 AM

Equities Research Analysts' Ratings Reiterations for May, 11st (AGCO, ARX ...
Junction Report - May 12, 2012

AGCO Corp. (NASDAQ: AGCO) had its â€œoutperformâ€ rating re-affirmed by analysts at Zacks. They now have a $52.00 price target on the stock.

View the full article

#47 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 21 May 2012 - 12:46 PM

BioTime Completes Merger of XenneX, Inc. into LifeMap Sciences, Inc.
MarketWatch (press release) - 5 hours ago

ALAMEDA, Calif., May 21, 2012 (BUSINESS WIRE) -- BioTime, Inc. (nyse mkt:BTX) and its subsidiary LifeMap Sciences, Inc. today announced that they have completed the acquisition of XenneX, Inc. through a merger of XenneX into LifeMap Sciences.

XenneX completes merger with LifeMap Sciences - Mass High Tech

View the full article

#48 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 18 May 2012 - 05:02 PM

Augusta Resource Corporation Announced The Retirement Of Senior Vice President ...
Galaxy Stocks - May 18, 2012

View the full article

#49 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 15 May 2012 - 01:15 AM

Furiex Gets Product Rights for Priligy; Celsion Announces Resubmission of ...
BioMedReports (subscription) - May 15, 2012

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 14, 2012.

View the full article

#50 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 14 May 2012 - 12:47 PM

HyStem®-C Demonstrated Effective when Formulated with Human Heart Cells and ...
MarketWatch (press release) - May 14, 2012

ALAMEDA, Calif., May 14, 2012 (BUSINESS WIRE) -- BioTime, Inc. (nyse mkt:BTX) announced today the publication of a scientific paper demonstrating the effectiveness of HyStem®-C in the transplantation of heart muscle-derived cells in an animal model ...

HyStem®-C Demonstrated Effective when Formulated with Human Heart Cells and ... - Genetic Engineering News

View the full article

#51 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 11 May 2012 - 06:37 PM

BioTime (NYSE AMEX: BTX) Q1/12 Results and Highlights
Proactive Investors USA & Canada - May 11, 2012

Net loss was $5M or $0.10 per share, compared to a net loss of $3.4M or $0.07 per share for Q1/11. Q1/12 total revenue (including royalties from product sales and other revenue, revenue recognition of deferred license fees and grant income), ...

View the full article

#52 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 10 May 2012 - 10:02 PM

BioTime Announces First Quarter 2012 Financial Results and Recent Corporate ...
Reuters - May 10, 2012

Alameda, Calif., May 10, 2012 - BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the first quarter ended March 31, ...

View the full article

#53 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 21 May 2012 - 12:15 PM

Osiris Therapeutics (NASDAQ:OSIR) Wins Stem Cell Medicine Approval; Shares Sky ...
PT News - 7 hours ago

Osiris Therapeutics (NASDAQ:OSIR) Wins World's First Stem-Cell Therapy Approval - Gaining Green

View the full article

#54 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 22 May 2012 - 12:45 PM

BioTime, Inc. And Subsidiary LifeMap Sciences, Inc. Announce Agreement To Market Malacards
Reuters Key Development - 2 hours ago

View the full article

#55 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 22 May 2012 - 02:06 PM

Cardium (CXM) to Present at Sachs 2012 Science, Partner, and Investment Forum
BiotechStockTrader.com - 2 hours ago

Cardium Therapeutics (NYSE Amex: CXM), a health sciences and regenerative medicine company focused on the acquisition of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs ...

View the full article

#56 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 23 May 2012 - 02:40 AM

This Just In: More Upgrades and Downgrades
DailyFinance - 13 minutes ago

By Rich Smith (TMFDitty), The Motley Fool At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral.

View the full article

#57 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 23 May 2012 - 12:46 PM

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards(R ...
MarketWatch (press release) - 2 hours ago

ALAMEDA, Calif. & CAMBRIDGE, Mass., May 23, 2012 (BUSINESS WIRE) -- XenneX, a Division of LifeMap Sciences, Inc. and BioTime, Inc. (nyse amex:BTX), announced today the release of GeneCards®, Version 3.08, on May 20, 2012.

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards ... - Genetic Engineering News (press release)

View the full article

#58 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 23 May 2012 - 06:48 PM

US FDA Staff Shoot Down Pfizer Rare Disease Drug; Repros Updates Special ...
Proactive Investors USA & Canada - 4 minutes ago

Below is a look at some of the headlines for companies that made news in the healthcare sector on May 22, 2012. US drug reviewers recommended on Tuesday rejecting a Pfizer Inc (NYSE:PFE) drug because the data did not prove it worked well in treating a ...

View the full article

#59 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 23 May 2012 - 06:48 PM

US FDA Staff Shoot Down Pfizer Rare Disease Drug; Repros Updates Special ...
Proactive Investors USA & Canada - 3 hours ago

View the full article

#60 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 23 May 2012 - 02:40 AM

This Just In: More Upgrades and Downgrades
DailyFinance - 21 hours ago

By Rich Smith (TMFDitty), The Motley Fool At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral.

View the full article